Pharmac makes access to Estradiol TDP Mylan (oestradiol) patches easier for New Zealanders
Pharmac is making it easier for people to access oestradiol treatment, by making it easier and more convenient for people to use the Estradiol TDP Mylan brand of patches.
From 1 September 2026, people will be able to collect up to three months’ supply of Estradiol TDP Mylan patches from their pharmacy at a time, rather than the previous one month’s supply. Pharmac will also remove the current limit of two patches per week for this brand, allowing people to get more of their treatment at once.
“People have told us they want to be able to collect more of their treatment in one go, rather than needing to go back to the pharmacy as often,” says Pharmac’s Chief Advisor Pharmaceuticals, Adrienne Martin.
“These changes make it much easier for people to use the Estradiol TDP Mylan brand of patches as an option, where it is right for them.”
Pharmac funds a range of oestradiol treatments so that people can use what is most suitable for them, including two brands of patches, Estradiol TDP Mylan and Estradot, as well as other options such as gel and tablets.
“We know that while different brands of patches are expected to work the same, that hasn’t been everyone’s experience,” says Martin. “Having options matters and making Estradiol TDP Mylan patches easier to use helps more people access it where it is right for them.”
Estradot patches continue to be affected by global supply constraints, and supply remains tight and uncertain.
“Because of this, we’re not making the same changes to the dispensing limits of the Estradot brand of patches,” says Martin. “Instead, we’re making it easier to use Estradiol TDP Mylan patches, which has more secure supply.
“This will help reduce pressure on the limited Estradot patches stock and preserve it for people who need it.”
This approach has been informed by engagement with clinicians and advocacy groups, who have helped shape the changes to better meet people’s needs.